Systemic therapy stands as a cornerstone in contemporary cancer treatment, representing a holistic approach that targets cancer cells throughout the body. This modality encompasses chemotherapy, targeted therapy, immunotherapy, and hormone therapy, each tailored to disrupt cancer's growth and spread. Chemotherapy employs cytotoxic drugs to eradicate rapidly dividing cancer cells, while targeted therapy zeroes in on specific molecular alterations driving cancer progression. Immunotherapy harnesses the body's immune system to recognize and destroy cancer cells, while hormone therapy interferes with hormone signaling pathways crucial for certain cancers, like breast and prostate cancer. These systemic approaches not only combat primary tumors but also address metastatic disease, enhancing survival rates and improving patients' quality of life. As cancer research continues to unveil novel therapeutic targets, systemic therapies remain pivotal in the evolving landscape of oncology.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States